Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial
Official title:
Dyspnea Self-Management: Internet or Face-to-Face
Chronic obstructive pulmonary disease, including emphysema and chronic bronchitis, is the
fourth most common cause of death and the second leading cause of disability in the United
States. COPD is estimated to be responsible for more than 13.4 million physician visits and
13% of hospitalizations nationally. These hospitalizations are usually caused by acute
exacerbations characterized by an increase in symptoms including dyspnea or shortness of
breath (SOB), cough, wheezing, and sputum production. The significant disability for people
with COPD is primarily due to the symptom of dyspnea (shortness of breath) that affects an
individual's quality of life more than does the physiological impairment. Despite optimal
medical and pharmacological therapy, most people with COPD continue to suffer from chronic
and progressive dyspnea and other symptoms of cough and fatigue.
We have previously shown that an individualized face-to-face dyspnea self-management program
was effective in improving dyspnea with activities of daily living (ADL), physical
functioning, and self-efficacy for managing dyspnea. Using an experimental longitudinal
design, the i-DSMP will be compared to the Face-to-Face Dyspnea Self-Management Program
(f-DSMP) and to an Attention Control (AC) intervention
At the present time, education about symptom management for patients and treatments,
including exercise, are primarily provided within structured and episodic pulmonary
rehabilitation (PR) programs. These PR programs are of short duration, are available for
only a small percentage of people because they are expensive and not covered by all third
party payers, and often require travel by patients who are disabled. Given estimates of 10
to 24 million U.S. adults with COPD,most of who would benefit from PR, only less than 0.1%
can be accommodated at any given time. In the US the maintenance or exercise programs
following PR are not reimbursed and, therefore, not available for most patients.
A number of self-management programs have been tested in multiple chronic diseases,but there
has been less study of self-management programs for patients with COPD. The few
self-management programs for COPD that include only education and limited skills training
have not significantly improved symptoms. Home-based PR and self-management programs with
nurse home visits have been studied and provide a less costly and accessible alternative.
Clearly there is a growing need for more accessible and alternative avenues for providing
ongoing support and therapy for COPD patients.
The Internet provides a new exciting delivery channel that offers patients with disabilities
an opportunity for greater involvement in health care decision-making and unparalleled
opportunities to learn, inform, and communicate with one another and for health care
providers to support patients' self-management efforts. Several Internet-based studies for
other chronic illnesses have increased self-efficacy for symptom management, perception of
available support, and patients' involvement in health care decision making, while reducing
symptoms and health care costs. The only published study evaluating the use of the internet
to support self-management in COPD patients was our pilot study for this proposal. Our study
demonstrated an improvement in both self-efficacy and dyspnea with daily activities
measures. This study will expand on the findings of our pilot study.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03282019 -
Study of Long-term HFNC for COPD Patients With HOT
|
N/A | |
| Completed |
NCT05573464 -
A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With the Hydrofluoroolefin Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
|
Phase 3 | |
| Recruiting |
NCT06040086 -
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations
|
Phase 3 | |
| Not yet recruiting |
NCT06376994 -
Multi-Center Clean Air Randomized Controlled Trial in COPD
|
Phase 3 | |
| Completed |
NCT02926534 -
Cross-Sectional Study of COPD Prevalence Among Smokers, Ex-smokers and Never-Smokers in Almaty, Kazakhstan
|
N/A | |
| Completed |
NCT02797392 -
Feasibility of a Preventive Program Against Lifestyle Related Diseases
|
N/A | |
| Completed |
NCT02728674 -
Management of Patients With Respiratory Symptoms in Sweden
|
N/A | |
| Recruiting |
NCT02415478 -
Bronchioscopic Lung Volume Reduction (BLVR)
|
N/A | |
| Completed |
NCT02512510 -
Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT02774226 -
Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
| Completed |
NCT03487406 -
Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)
|
Phase 2 | |
| Completed |
NCT02518139 -
A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT02459080 -
Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Withdrawn |
NCT01908933 -
Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema
|
Phase 3 | |
| Completed |
NCT01615484 -
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
|
N/A | |
| Completed |
NCT01893476 -
A Pragmatic Cluster Trial of a Tailored Intervention to Improve COPD Management
|
N/A | |
| Completed |
NCT01908140 -
Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT01701869 -
Microbiology & Immunology of the Chronically-inflamed Airway
|
N/A | |
| Recruiting |
NCT02527486 -
Seoul National University Airway Registry
|
N/A | |
| Terminated |
NCT01388920 -
Efficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle Wasting
|
Phase 2 |